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While the role of mitochondrial Ca2+ homeostasis in
cell pathophysiology is widely accepted, the possi-
bility that cAMP regulates mitochondrial functions
has only recently received experimental support.
The site of cAMPproduction, its targets, and its func-
tions in the organelles remain uncertain. Using a va-
riety of genetic/pharmacological tools, we here
demonstrate that the mitochondrial inner membrane
is impermeable to cytosolic cAMP, while an autono-
mous cAMP signaling toolkit is expressed in the ma-
trix. We demonstrate that rises in matrix Ca2+ power-
fully stimulate cAMP increases within mitochondria
and that matrix cAMP levels regulate their ATP syn-
thesizing efficiency. In cardiomyocyte cultures, mito-
chondrial cAMP can be increased by treatments that
augment the frequency and amplitude of Ca2+ oscil-
lations within the cytosol and organelles, revealing
that mitochondria can integrate an oscillatory Ca2+
signal to increase cAMP in their matrix. The present
data reveal the existence, within mitochondria, of a
hitherto unknown crosstalk betweenCa2+ and cAMP.
INTRODUCTION
The discovery of the major role played by mitochondria in Ca2+
signaling, the understanding of their central role in cell death,
and the increasing awareness of the linkage between mitochon-
drial dysfunctions andmajor human diseases have all led to a re-
newed interest in these organelles.While the role ofmitochondria
in Ca2+ homeostasis has been extensively investigated, the other
major secondmessenger, cAMP, has remained formany years at
the periphery of the mitochondrial saga, and its role in mitochon-
drial pathophysiology was hardly considered until recently. In the
last years, however, the role of cAMP inmodulatingmitochondrial
functions has been re-evaluated. DiPilato and coworkers, using a
fluorescent cAMP sensor in live cells, concluded that cAMP pro-
duced in the cytoplasm diffuses rapidly into the mitochondrial
matrix (DiPilato et al., 2004); Acin-Perez and coworkers, on theCcontrary, argued that the innermitochondrialmembrane is imper-
meable to cAMP and suggested that the organelles are endowed
with a cAMP signaling cascade wholly contained in their matrix
(Acin-Perez et al., 2009). They suggested that cAMP is generated
inside the matrix by a soluble form of adenylate cyclase (sAC)
(Chen et al., 2000) in response to bicarbonate; in turn, cAMP ac-
tivates a mitochondrial isoform of protein kinase A, PKA, leading
to the phosphorylation and activation of the respiratory chain
(Acin-Perez et al., 2009, 2011a). In addition, phosphoproteomic
studies revealed the presence of a number of mitochondrial
phosphoproteins (Balaban, 2010; Boja et al., 2009; Hopper
et al., 2006), some of which are potential targets of PKA (Zhao
et al., 2011). On the other hand, whereas it is now firmly estab-
lished that the outer (and possibly also the inner) mitochondrial
membrane is enriched in PKA anchoring proteins (Alto et al.,
2002; Carlucci et al., 2008; Chen et al., 1997; Huang et al.,
1999; Liu et al., 2003; Means et al., 2011) and that phosphoryla-
tion of outer membrane proteins by cytosolic PKA has important
functional effects in the organelles (Danial et al., 2003; Gomes
et al., 2011; Harada et al., 1999), no recognizable mitochondrial
signal sequence is present either in the R or C PKA subunits.
Hereweshow that changes in cAMPoccur insidemitochondria
of intact cells and that sAC is indeed the local cAMPsource, while
no diffusion of cytosolic cAMP takes place in healthy organelles.
We also demonstrate that cAMP is generated in the matrix not
only in response to changes in HCO3
 concentration, but also
upon increases in matrix Ca2+ levels. In cardiac myocytes in
culture, an increase in the frequency and amplitude of Ca2+ oscil-
lations, within cytoplasm and mitochondria, elicited by b-adren-
ergic stimulation or by the transmembrane AC (tmACs) activator
forskolin, results in a rapid reversible increase of matrix cAMP
level. Finally, we provide evidence that cAMP in the matrix con-
tributes to the regulation of mitochondrial ATP production. The
pharmacological sensitivity of the cAMP-dependent increase in
mitochondrial ATP only in part overlaps that of cytosolic PKA.
RESULTS
Sensors for Monitoring Mitochondrial cAMP
Generation of FRET-Based cAMP Sensors Selectively
Targeted to the Mitochondrial Matrix
DiPilato et al. suggested that cytosolic cAMP increases are par-
alleled by similar changes within the mitochondrial matrixell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc. 965
Figure 1. Mitochondrial Localization of the cAMP Sensor and FRET Changes Caused by a Membrane-Permeable cAMP Analog
(A) Schematic representation of the matrix-targeted cAMP sensor 4mtH30. Four copies of the human COXVIII targeting sequence have been fused to the N
terminus of H30, which contains, between ECFP and EYFP, thewhole Epac1 protein, rendered catalytically inactive and deprived of themembrane-targeting DEP
domain.
(B) Left panel: Representative epifluorescence images of HeLa cells transiently expressing 4mtH30, 24 hr after transfection. The cAMP probe localizes pref-
erentially in rod-like elongated structures, though in some cells (see, for example, the upper cell) a significantmislocalization in the cytosol is evident. The sensors’
localization, however, becomes exclusively mitochondrial in almost all cells 48 hr after transfection. Right panel: Representative images of a HeLa cell co-
transfected with the cAMP sensor 4mtH30 (green) and the mitochondrial fluorescent protein mtRFP (red). The colocalization of 4mtH30 with mtRFP indicates a
very good overlapping between the two signals (yellow). Similar results were obtained in CHO cells.
(C) Left panel: Representative confocal image of the 4mtH30_E4 stable cell line indicating that these cells correctly express 4mtH30 within mitochondria, without
any appreciable cytosolic mistargeting. Middle panel: Representative kinetics ofDR/R0 recorded in several 4mtH30_E4 cells challenged, in the presence of IBMX
(100 mM), with Sp-8-pCPT-20-O-Me-cAMPS (100 mM), a highly membrane-permeable cAMP analog that selectively activates Epac. Right panel: Blue columns:
average percentage DR/R0 increases (mean ± SEM) observed upon addition of 10 or 100 mM Sp-8-pCPT-2
0-O-Me-cAMPS, in the presence of 100 mM IBMX, to
cells transiently expressing cytosolic H30. Number of cells (n) = 10 for each condition. Yellow columns: as above, but in 4mtH30_E4, i.e., the cell line stably
expressing the mitochondrial targeted probe, n = 12. In these and the following experiments the average values were obtained from at least three independent
experiments and the error bars in the columns represent SEM.
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cAMP and Ca2+ Crosstalk within Mitochondria(DiPilato et al., 2004). Using the very same sensor, we observed
that the probe is extensively missorted to the cytosol with only a
marginal accumulation in mitochondria (not shown). We thus
generated new cAMP sensors with improved mitochondrial tar-
geting (Filippin et al., 2005) by fusing repetitive (two or four
copies) targeting sequences from subunit VIII of the human cyto-
chrome oxidase (COX) at the N terminus of either the cAMP
sensor Epac1-camp (Nikolaev et al., 2004) (not shown) or CFP-
Epac(dDEP-CD)-YFP, named H30 (Ponsioen et al., 2004) (Fig-
ure 1A). Out of the different constructs generated, we selected
4mtH30, as it displays the largest dynamic changes in response
to cAMP variations. When cells transiently expressing 4mtH30
were analyzed 24 hr from transfection, the probe was in some
cells partially missorted to the cytosol (Figure 1B, left panel),
but it was almost exclusively mitochondrial after 48 hr (Figure 1B,966 Cell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc.right panel). The selective localization in the matrix was verified
as described in Supplemental Information (see also Giacomello
et al., 2010). A CHO cell line stably expressing the 4mtH30 probe
was generated. Confocal images of the 4mtH30_E4 stable line
(Figure 1C, left) indicate that 4mtH30 is correctly localized in
mitochondria, without any appreciable cytosolic mistargeting.
Changes in cAMP levels were assessed bymeasuring the 480/
540 nm emission ratio upon excitation at 430 nm and presented
as DR/R0, where R is the ratio at time t, R0 is the ratio at time 0,
andDR =RR0. Typical kinetics ofDR/R0 in several 4mtH30_E4
cells challenged with Sp-8-pCPT-20-O-Me-cAMPS, a highly
membrane-permeable Epac selective cAMP analog, are pre-
sented in Figure 1C (middle panel). The right panel of
Figure 1C summarizes the maximal DR/R0 changes in cells ex-
pressing 4mtH30 or cytosolic H30, induced by 10 mM or
Figure 2. Mitochondria Are Impermeable to
Cytosolic Changes of cAMP
(A–D) Representative kinetics of DR/R0 changes
upon addition of forskolin (25 mM) followed by
IBMX (100 mM) recorded in: (A) a representative
HeLa cell transiently transfected with 4mtH30 and
expressing the sensor mistargeted to the cytosol,
(B) two representative HeLa cells transiently ex-
pressing 4mtH30 in the mitochondrial matrix, and
(C) four stably expressing 4mtH30_E4 cells. In the
insets of (A)–(C), the fluorescence pattern of the
probe distribution in the analyzed cells is pre-
sented. The average DR/R0 increases (mean ±
SEM) caused by forskolin and forskolin + IBMX are
presented in (D) in cells transiently expressing
cytosolic 4mtH30 (n = 8), 4mtH30 (n = 7), and in the
stable line 4mtH30_E4 (n = 20). IBMX caused
a very small but significant rise of DR/R0 in
the mitochondrial matrix of the stable line
4mtH30_E4, whether added alone (not shown) or
in the presence of forskolin: *p = 0.025, two-tailed
paired t test.
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cAMP and Ca2+ Crosstalk within Mitochondria100 mM Sp-8-pCPT-20-O-Me-cAMPS in the presence of the
PDE inhibitor IBMX (3-isobutyl-1-methylxanthine). The 4mtH30
sensor in the matrix environment displays a maximum DR com-
parable to that displayed by cytosolic H30.
cAMP Changes within the Mitochondrial Matrix
cAMPGenerated in theCytosol DoesNotDiffuse into the
Mitochondrial Matrix
We first tested whether cAMP generated in the cytosol could
enter the mitochondrial matrix. To this end, the classical tmACs
activator forskolin was used to induce a rise in cAMP. Figure 2A
shows a representative kinetic of DR/R0 changes in the cytosol,
recorded in a HeLa cell with a significant fraction of 4mtH30 mis-
targeted in the cytosol. Similar results were obtained in cells
transiently expressing cytosolic H30 (not shown). In both cases,
25 mM forskolin caused a clear rise in cAMP. On the contrary, in
HeLa cells transfected with 4mtH30 in which the probe is
correctly targeted to the mitochondria (Figure 2B), or in cells sta-
bly expressing 4mtH30 (4mtH30_E4) (Figure 2C), forskolin had
no effect on DR/R0. The generic PDE inhibitor IBMX, added after
forskolin, caused a dramatic further increase in cytosolic cAMP
(Figure 2A) and a very small but significant increase in mitochon-
drial cAMP (Figure 2B and 2C). This latter result suggests that
mitochondrial cAMP could be modulated by endogenous
PDEs. The average changes in cytosolic and matrix cAMP
upon addition of forskolin and IBMX are summarized in
Figure 2D.
Ca2+ Increases Induce cAMP Rises in the Mitochondrial
Matrix
Indirect evidence has been provided indicating that sAC, in addi-
tion to its cytosolic location, is also present in the mitochondrialCell Metabolism 17, 965–matrix (Acin-Perez et al., 2009). The enzy-
matic activity of sAC is increased by
HCO3
 and Ca2+ in a synergistic or addi-
tive way (Jaiswal and Conti, 2003; Litvin
et al., 2003; Steegborn et al., 2005a,
2005b). To test whether Ca2+ couldmodulate mitochondrial cAMP, cells were incubated in a Ca2+-
free medium and challenged first with the IP3-generating agonist
ATP in combination with tert-Butylhydroquinone (TBHQ), an in-
hibitor of the sarco-endoplasmic reticulum Ca2+ ATPase. This
protocol induces the release of Ca2+ from the ER; CaCl2 was
then reintroduced into the medium. Under these conditions ca-
pacitative Ca2+ influx (CCE) is maximally activated (Parekh and
Putney, 2005), resulting in a large and sustained increase in
Ca2+ entry from the medium (Putney, 2009) (Figure S1A).
We next measured, using the same protocol, the dynamics of
mitochondrial cAMP (mt-cAMP) in the 4mtH30_E4 cell line. Addi-
tion of extracellular ATP + TBHQ caused a transient, small, and
often unappreciable increase inmt-cAMP (Figure 3A). Ca2+ read-
dition caused, in almost all cells, a slow but marked increase in
mt-cAMP; the final HCO3
 administration induced a further in-
crease (Figure 3A). The small mt-cAMP response to ATP +
TBHQ increased in the presence of CGP 37157, a potent inhib-
itor of the mitochondrial Na+/Ca2+ exchanger (mNCX) (Figures
S1B–S1D).
It has been demonstrated that overexpression of the mito-
chondrial Ca2+ uniporter (MCU) (Baughman et al., 2011; De Ste-
fani et al., 2011) results in a substantial increase in the amplitude
of mitochondrial Ca2+ accumulation both in response to Ca2+
release from stores and to Ca2+ influx from the medium (De Ste-
fani et al., 2011).We thus repeated the experiment in 4mtH30_E4
cells transiently expressing a mCherry-tagged version of MCU.
In this case the amplitudes of the mt-cAMP rise in response to
ATP (Figure 3B) or CCE (Figure 3C) were substantially increased.
The percentage of ATP-responsive cells in the 4mtH30_E4 coex-
pressing MCU increased from 41% to 75%. The average mt-
cAMP increases caused by ATP + TBHQ followed by Ca2+ in975, June 4, 2013 ª2013 Elsevier Inc. 967
Figure 3. Ca2+ Increases in the Mitochondrial Matrix Are Paralleled by Mitochondrial cAMP Rises
(A) Representative kinetics ofDR/R0 changes recorded in typical 4mtH30_E4 cells, stimulated, in sequence, with ATP (50 mM) + TBHQ (30 mM), CaCl2 (2 mM), and
NaHCO3 (50mM). The cells were first incubated in Ca
2+-freemedium (containing 100 mMEGTA), and the perfusion buffer was changed, where indicated, with the
same medium supplemented with ATP and TBHQ, followed by medium containing CaCl2 +TBHQ and CaCl2+ TBHQ and HCO3
.
(B and C) Representative kinetics of DR/R0 changes recorded in typical 4mtH30_E4 cells overexpressing amCherry-tagged version of MCU, stimulated with ATP
(50 mM) + TBHQ (30 mM) (B) followed by CaCl2 (2 mM) (C).
(D and E) Average amplitude of the cAMP responses to ATP and CCE (mean ± SEM), without (n = 15, *p = 0.019) and with MCU overexpression (n = 15, **p =
0.009).
(F) Average amplitude of the cAMP responses to ATP andCCE (mean ± SEM), in 4mtH30_E4 cells treatedwith a scrambled siRNA (n = 23) or with a siRNA forMCU
(n = 31); ***p = 0.001 for ATP and ***p = 2.6 3 106 for CCE. See also Figure S1.
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cAMP and Ca2+ Crosstalk within Mitochondriacontrols and MCU-overexpressing cells are summarized in Fig-
ures 3D and 3E. On the contrary, when performing RNA silencing
of MCU, both the responses to ATP and to CCE were signifi-
cantly decreased (Figure 3F).
HCO3
– Effect on Mitochondrial cAMP
The best-characterized activator of sAC is HCO3
 (Steegborn
et al., 2005b). The presence of 10 mM HCO3
 in the medium
increased both the number of ATP + TBHQ responsive cells
(from 41% to 80%) and the size of their response (Figures 4A
and 4B). The DR/R0 increase due to CCE, instead, was almost
unaffected by the presence of 10 mM HCO3
 in the medium
(not shown). Figure 4C shows representative kinetics of DR/R0
changes in 4mtH30_E4 cells treated only with 50 mM NaHCO3.
The kinetic of the response to HCO3
 was often biphasic, with
an initial transient rise phase followed by a lower but sustained
plateau (for over 30 min). The mean amplitude of the sustained
plateau phase is summarized in Figure 4D. The response to
HCO3
 was significantly decreased in cells pretreated with the
sAC inhibitor 2-hydroxy estradiol, 2-OHE (10 mM) (Figures 4C
and 4D). The classical sAC inhibitor KH7, instead, caused a par-
adoxical dramatic increase of the mitochondrial DR/R0, but it968 Cell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc.was accompanied by a complete collapse of mitochondrial
membrane potential (Figure S2) and DpH (not shown); accord-
ingly, KH7 was not further tested. The overexpression of MCU
had no effect on the cAMP response to HCO3
 (not shown).
The interpretation of the effect of HCO3
 and of the other treat-
ments on cAMP using GFP-based probes is complicated by the
possible influence of pH changes on the probe signal, as most
GFP mutants are sensitive to pH changes in the physiological
range (Abad et al., 2004; Llopis et al., 1998). To monitor the pH
of the mitochondrial matrix, we transfected CHO cells with
mtAlpHi, a genetically encoded mitochondrial pH indicator
(Abad et al., 2004). The details of these experiments are
presented in the Supplemental Information (Figure S3).
We conclude that treatment with IBMX, EHNA (erythro-9-(2-
hydroxy-3-nonyl)adenine), and 2-OHE had no appreciable effect
on matrix pH, while a small and variable transient alkalinization
was observed both upon ATP + TBHQandCCE activation. Given
that an alkalinization leads to an apparent decrease in cAMP, this
effect of mitochondrial Ca2+ uptake on matrix pH tends, if any-
thing, to slightly underestimate the DR/R0 increase. A significant
transient acidification was observed upon addition of 50 mM
Figure 4. HCO3
– Effect on Mitochondrial cAMP
(A) Representative kinetics of DR/R0 changes recorded in typical 4mtH30_E4 cells stimulated with ATP (50 mM) + TBHQ (30 mM), in the absence (black) or in the
presence (gray) of 10 mM HCO3
 in the medium.
(B) Average amplitude of the responses to ATP + TBHQ (mean ± SEM) in the absence or presence of HCO3
 (n = 61 and n = 12, respectively; ***p = 7.33 105).
(C) Representative kinetics of DR/R0 changes upon HCO3
 addition (50 mM) in 4mtH30_E4 cells pretreated for 30 min with DMSO (black traces) or with the sAC
inhibitor 2-hydroxy estradiol (2-OHE, 10 mM, gray trace).
(D) Average amplitude of the responses to HCO3
 (mean ± SEM) (n = 71 controls, n = 31 2-OHE treated; **p = 0.0049).
(E) Representative kinetics of DR/R0 changes upon addition of HCO3
 (50 mM) in CHO cells transiently expressing 4mtH90, pretreated for 30 min with DMSO
(gray trace) or 2-OHE (10 mM, white trace).
(F) Average amplitude of theDR/R0 changes (mean ± SEM) caused by HCO3
 (n = 23 and n = 21 for controls and 2-OHE treated, respectively; *p = 0.010). See also
Figures S2 and S3.
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cAMP and Ca2+ Crosstalk within MitochondriaNaHCO3 (Figures S3E and S3F). We thus measured FRET
changes in CHO cells transiently expressing a different cAMP
sensor, 4mtH90 (kind gift of Dr. A. Hofer and Dr. K. Lefkimmiatis),
much less pH sensitive than H30. Figure 4E shows typical ki-
netics of FRET changes in CHO cells expressing 4mtH90 and
challenged with 50 mM HCO3
. The byphasic rise of DR/R0
was not observed, while the inhibitory effect of 2-OHEwasmain-
tained, as summarized in Figure 4F.
Mitochondrial cAMP IsGenerated by sACandModulated
by PDE
The above experiments and previous work (Acin-Perez et al.,
2009) suggest that sAC is the enzyme responsible for the gener-
ation of cAMP in the mitochondrial matrix. To verify this conclu-
sion, we performed genetic ablation of sAC by RNA silencing
(see also Figure S4). Themt-cAMP increase caused by CCE acti-
vation was strongly reduced in silenced cells (Figure 5A),
although the silencing of sAC had no effect on CCE (not shown).
The CCE-dependent rise in mt-cAMP was inhibited, as in the
case of HCO3
, by 2-OHE (Figure 5B), whereas it was unaffected
by the carbonic anhydrase inhibitor acetazolamide (100 mM) andCby the classical tmACs inhibitor 20,30-dideoxyadenosine (ddAdo,
100 mM) (not shown). Next, we tested the effect of overexpress-
ing a mitochondria-targeted sAC. The 4mtH30_E4 cell line was
cotransfected with a mitochondrial version of sAC (mt_trsAC)
and with a cytosolic RFP, as a marker of transfection. Figure 5C
summarizes the results on mt-cAMP induced by CCE activation
in cells cotransfectedwithmt_trsAC andRFP. Overexpression of
mt_trsAC markedly increased the Ca2+-induced mt-cAMP pro-
duction, and also in this case 2-OHE reduced the cAMP
response to CCE (see Figure 5B). Finally, the absolute values
of R, a function of the resting mt-cAMP levels, were slightly,
but significantly, higher in unstimulated cells overexpressing
mt_trsAC compared to untransfected controls (0.504 ± 0.007,
n = 61 versus 0.486 ± 0.006, n = 97; p = 0.048).
In Figure 2 we showed that IBMX had a very small effect on
resting mt-cAMP. In order to further address the role of PDEs,
IBMX was added to cells whose cAMP was increased by either
HCO3
 or CCE. Figure 5D shows that IBMX caused in both cases
a much larger mt-cAMP rise, and its effect was potentiated by
overexpression of both MCU and mt_trsAC. It has beenell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc. 969
Figure 5. sAC and PDE Activities Modulate
Mitochondrial cAMP
(A) Average (mean ± SEM) DR/R0 changes elicited
by CCE (with the protocol described in Figure 3) in
4mtH30_E4 control cells (n = 72), in cells treated
with the HMR1-MR2 siRNAs couple (n = 46), or
with a control siRNA (n = 83) (p = 0.27 ctrl versus
ctrl siRNA; ***p = 1.9 3 109 siRNA versus ctrl;
***p = 7.2 3 106 siRNA versus ctrl siRNA).
(B) Average (mean ± SEM) DR/R0 changes elicited
by CCE in 4mtH30_E4 control cells pretreated for
30 min with DMSO (n = 11) or with 2-OHE, 10 mM
(n = 70), ***p = 0.00018; average (mean ± SEM)
DR/R0 changes elicited by CCE in 4mtH30_E4
cells cotransfected with a cytosolic RFP and
mt_trsAC. Only cells coexpressing RFP were
considered. Cells were treated for 30 min with
DMSO (n = 15), with 2-OHE 10 mM (n = 24), or with
2-OHE 100 mM (n = 11). p = 0.11 for 2-OHE 10 mM
versus controls and ***p = 0.0001 for 2-OHE
100 mM versus controls.
(C) Average (mean ± SEM) DR/R0 changes elicited
by CCE in 4mtH30_E4 control cells (n = 19) and
cells cotransfected with a cytosolic RFP and
mt_trsAC (n = 43). Only cells coexpressing RFP
were considered. **p = 0.0094. Inset: Confocal
images of representatives CHO cells transfected
with a RFP-tagged version of mt_trsAC.
(D) Average (mean ± SEM) DR/R0 changes elicited
by the administration of IBMX (100 mM) on:
4mtH90-expressing cells previously stimulated
with 50 mM NaHCO3 (gray column; n = 23; ***p =
5.2 3 108 versus response to only NaHCO3);
4mtH30_E4 cells previously subjected to CCE
(black column; n = 26; **p = 0.0043 versus
response only to CCE); 4mtH30_E4 cells over-
expressing MCU and previously subjected to
CCE (white column; n = 21; **p = 0.0021 versus
response only to CCE); RFP-expressing
4mtH30_E4 cells transfected with RFP + mt_trsAC
subjected to CCE (black-striped column; n = 43;
**p = 0.0058 versus response only to CCE). The
gray-striped column refers to the effect of the
PDE2-selective inhibitor EHNA onRFP-expressing
4mtH30_E4 cells transfected with RFP + mt_trsAC
previously subjected to CCE (n = 7; **p = 0.008
versus response only to CCE; p = 0.67
versus response to CCE/IBMX). See also Figures
S3 and S4.
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PDE2A (Acin-Perez et al., 2011b). Indeed, administration of
10 mMEHNA, a PDE2-selective inhibitor, was almost as effective
as IBMX at increasing the mt-cAMP rise in response to CCE




It has been proposed that a sAC-cAMP-
PKA signaling pathway, wholly contained
within mitochondria, modulates the respi-
ratory chain enzymes through PKA-dependent phosphorylation (Acin-Perez et al., 2009, 2011a;
Papa et al., 2008).We thusmeasuredmitochondrial ATP concen-
tration, [ATP]m, in intact HeLa cells, making use of a matrix-tar-
geted luciferase, mtLUC. Similar results were obtained in CHO
cells. Figure 6 shows that the resting [ATP]m is increased 40%
Figure 6. Effect of sAC Activity, mt-cAMP
Increases, and PKA Inhibition/Activation
on [ATP]m
(A) Normalized (control = 1) average (mean ± SEM)
[ATP]m basal levels measured in HeLa cells
transfected with mtLUC alone or mtLUC +
mt_trsAC. n = 34 experiments, *p = 0.025. In these
and the following experiments, 30 min before
measurement the medium was substituted with a
HEPES-buffered Ringer-modified saline supple-
mented with luciferin (100 mM), and the cells were
incubated at room temperature (20C–22C). Each
condition was tested in triplicate in each experi-
ment, and the means are derived from three or
more independent experiments (as indicated). (A)–
(E): two-tailed paired t tests.
(B) Normalized average (mean ± SEM) [ATP]m
basal levels measured in cells cotransfected
with mtLUC (black) or mtLUC + mt_trsAC (gray).
Striped columns: The cells were incubated
with HMR1-MR2 siRNAs against trsAC, and the
basal luminescence measured was normalized to
luminescence measured in cells incubated with
control siRNA. Solid columns: the cells were
treated with 2-OHE, 10 mM or 100 mM, for 2 hr
before initiating the measurement, and the basal
luminescence measured was normalized to lumi-
nescence measured in untreated controls. Other
conditions as in (A). mtLUC_siRNA: n = 6, **p =
0.0071; mtLUC + mt_trsAC_siRNA: n = 3, *p =
0.022; mtLUC_2-OHE 10 mM: n = 4, *p = 0.036;
mtLUC_2-OHE 100 mM: n = 6, **p = 0.0035;
mtLUC + mt_trsAC_2-OHE 10 mM: n = 9, **p =
0.0096; mtLUC + mt_trsAC_2-OHE 100 mM: n = 4,
*p = 0.051.
(C) Normalized average (mean ± SEM) [ATP]m measured in cells transfected with mtLUC alone (black), mtLUC + mt_PKI (white), or mtLUC + mt_trsAC (gray).
Conditions as in (A). Striped columns: After initiating the [ATP]m measurement, the cells were treated with 100 mM IBMX for 15 min, and the final luminescence
values have been normalized to their initial values. mtLUC: n = 6, *p = 0.013; mtLUC + mt_trsAC: n = 5, *p = 0.028. Solid columns: After initiating the [ATP]m
measurement, CCE was initiated by addition of 2 mM CaCl2 (see also Figure S5). For each sample, the final luminescence values 2 hr after Ca
2+ addition have
been normalized first to their initial values, then to values of untreated controls. In the case of mt_PKI, the transfection resulted in a reduction of the initial [ATP]m to
about 45%of the control level (see E), and accordingly, the initial [ATP]m of the controls (cells transfectedwithmt_PKI and not subjected to CCE) has been set to 1;
the CCE activation did not increase significantly this level. mtLUC: n = 3, *p = 0.013; mtLUC + mt_trsAC: n = 6, *p = 0.040; mtLUC + mt_PKI: n = 3, p = 0.33.
(D) Normalized average (mean ± SEM) [ATP]m measured in cells transfected with mtLUC. Conditions as in (A). After initiating the [ATP]m measurement, the cells
were treated with several membrane-permeable cAMP analogs for 2 hr, and the final luminescence values were normalized to the initial values. The obtained
values were then normalized to untreated controls. 8Br-cAMP (1mM): n = 6, p = 0.94; Sp-8-pCPT-20-O-Me-cAMPS (100 mM): n = 9, p = 0.18; 8-CPT-6-Phe-cAMP
(100mM): n=10, **p =0.0077; Rp-8-CPT-cAMP (100mMand1mM): n = 9and3, respectively; *p =0.038 and **p 0.0067, respectively; H89 (10mM): n=4, *p =0.011.
(E) Normalized average (mean ± SEM) [ATP]m basal levels measured in cells transfected with mtLUC +mt_PKI (black) or with mtLUC +mt_trsAC +mt_PKI (gray).
Conditions as in (A). The basal luminescence measured was normalized to luminescencemeasured in untransfected controls. mtLUC +mt_PKI: n = 7; *p = 0.035;
mtLUC + mt_trsAC + mt_PKI: n = 22; ***p = 0.00011. Inset: confocal image of CHO cells transfected with a mCherry-tagged version of mt_PKI. See also Figures
S5 and S6.
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sAC reduced it both in mt_sAC-overexpressing and in control
cells (Figure 6B). 2-OHE significantly reduced [ATP]m, in a dose-
dependent manner (Figure 6B), while IBMX increased it (Fig-
ure 6C). The effect on [ATP]m of CCE activation was then tested.
Figure S5 shows typical changes in the kinetics of luciferase lumi-
nescence upon CCE activation, while in Figure 6C the average
percentage increases are summarized. In both mtLUC and
mtLUC + mt_trsAC transfected HeLa cells, both the rate and
extent of [ATP]m increase were augmented upon CCE activation.
Theeffect ofCCEon [ATP]mwasunaffected in thepresenceof the
carbonic anhydrase inhibitor acetazolamide (100mM,not shown).
Although the mechanism of PKA translocation into the mito-
chondrial matrix is still unknown, previous works suggest thatCthe intramitochondrial effects of cAMP are mediated through
the classical PKA pathway. We thus tested this hypothesis; to
inhibit PKA, we treated the cells either with Rp-8-CPT-cAMP, a
potent competitive inhibitor of cAMP binding to the PKA R sub-
unit, or with H89 (5-isoquinolinesulfonamide) that competes for
the ATP binding site of PKA C subunit. Both drugs clearly
reduced [ATP]m (Figure 6D). Alternatively, we generated a mito-
chondrial targeted version of the endogenous protein kinase in-
hibitor peptide (PKI) (Figure 6E, inset). As shown in Figure 6E,
mt_PKI overexpression reduced basal [ATP]m both in controls
and in mt_trsAC-transfected cells. As the overexpression of
mt_trsAC causes an increase of the basal [ATP]m, in absolute
terms the inhibition was comparable, reducing the basal
[ATP]m of both control cells and mt_trsAC-overexpressing cellsell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc. 971
Figure 7. cAMP Is Elicited by Ca2+ Increases in the Mitochondrial Matrix of Neonatal Rat Cardiomyocytes
(A) Representative images of a primary cultured neonatal cardiomyocyte transfected with the cAMP sensor 4mtH30 (green) and stained with MitoTracker orange
(red). The colocalization of 4mtH30 with MitoTracker orange is shown in yellow.
(B and C) Representative kinetics of DR/R0 changes recorded in a rat neonatal cardiomyocyte cotransfected with 4mtH30 and the nuclear cAMP sensor
H30_NLS, stimulated, in sequence, with NE (10 mM) and forskolin (25 mM), in the presence (B) or in the absence (C) of CaCl2 in the medium. The Ca
2+-freemedium
contained 100 mM EGTA and 30 mM TBQ.
(D) Average (mean ± SEM) DR/R0 changes recorded upon administration of NE (10 mM) and NE + forskolin (25 mM), in the presence or in the absence of CaCl2 in
the medium.DR/R0 changes have been recorded in the mitochondria of 4mtH30 (black columns; n = 9 in Ca
2+ and n = 3 in Ca2+-free; p = 0.11 for NE and p = 0.19
for forskolin) and 4mtH30 + MCU_mCherry-expressing cardiomyocytes (yellow columns; n = 7 in Ca2+ and n = 3 in Ca2+-free; *p = 0.04 for NE and **p = 0.005 for
forskolin). 4mtH30 versus 4mtH30 + MCU_mCherry: *p = 0.04 for NE and *p = 0.01 for forskolin. See also Figure S7.
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cAMP and Ca2+ Crosstalk within Mitochondriato 50% of the controls’ basal [ATP]m. Furthermore, in HeLa
cells cotransfected with mtLUC and mt_PKI and subjected to
CCE (Figure 6C), the rise of [ATP]m was strongly reduced by
mt_PKI expression. We also tested Sp-8-pCPT-20-O-Me-
cAMPS (100 mM), the most permeable (90 times more perme-
able than cAMP) of the Epac-selective cAMP analogs. Although
this compound clearly penetrates the mitochondrial matrix (see
Figure 1), it had no effect on [ATP]m (Figure 6D).
Taken as a whole, the above data appear consistent with the
suggestion that the target of mt-cAMP is indeed PKA. As a final
test, we investigated the effect on [ATP]m of two cAMP analogs,
8Br-cAMP (1 mM) and 8-CPT-6-Phe-cAMP (100 mM) (Figure 6D),
that are known potent activators of cytosolic PKA, though they
differ in termsofspecificityand inpermeabilityacrossmembranes.
Indeed, 8-CPT-6-Phe-cAMP is highly specific for PKA and 400-
fold more permeable than cAMP while 8Br-cAMP activates other
cAMP targets and is only twice as permeable as cAMP. Figure 6D972 Cell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc.shows that 8Br-cAMP had no effect on [ATP]m, while 8-CPT-6-
Phe-cAMP had a paradoxical effect, i.e., it decreased [ATP]m.
Yet 8Br-cAMP can reach the mitochondrial matrix and 8-CPT-6-
Phe-cAMP is effective in activating cytosolic PKA (Figure S6).
Increased Frequency and Amplitude of Mitochondrial
Ca2+ Oscillations Triggers Matrix cAMP Rises in
Neonatal Rat Cardiomyocytes
Maximally stimulatory doses of an IP3-generating agonist and
activation of CCE in cell lines represent useful experimental tools
to investigate the mechanism of cAMP control in mitochondria,
but bear little relevance for the physiological significance of
this pathway. To address the existence of a mitochondrial
Ca2+-cAMP crosstalk in a physiologically relevant model, we
measured the cAMP dynamics in the mitochondrial matrix of pri-
mary cultured neonatal rat cardiomyocytes transfected with
4mtH30. Confocal analysis of a 4mtH30-expressing cardiomyo-
cyte stained with MitoTracker is shown in Figure 7A. The sensor
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cAMP and Ca2+ Crosstalk within Mitochondriadistribution nicely overlapped that of themitochondrial probeMi-
toTracker red, and only a very small missorting of the cAMP
probe in the cytosol was observed in some cells. In order to
follow in the same cells mitochondrial and cytosolic cAMP
changes, we made use of the cotransfection with a nuclear
version of the same sensor, H30_NLS (Terrin et al., 2006). The
fluorescent signal of the sensors in the nucleus andmitochondria
can be easily distinguished, and it has been shown previously
that nuclear cAMP concentration closely follows the changes
occurring in the cytoplasm. The cells, incubated either in Ca2+-
containing (Figure 7B) or Ca2+-free medium (Figure 7C), were
treated with 10 mM norepinephrine (NE), followed by 25 mM for-
skolin. The mitochondrial Ca2+ changes in these conditions are
exemplified in Figure S7 (see also Robert et al., 2001). Figure 7B
shows that, in the presence of 2 mMCa2+, both NE and forskolin
evoke reversible cAMP increases, both inside and outside mito-
chondria; on the contrary (Figure 7C), when the same stimuli
were applied in a Ca2+-free medium, the cAMP increases in
the nucleus were unaffected, whereas in the matrix they were
drastically reduced. Under these latter conditions, removing
the stimulus by perfusing with a Ca2+-containing medium results
in a rapid return of nuclear cAMP to basal level, while the mito-
chondrial level increased (Figure 7C). Most relevant, if the cells
were also cotransfected with a mCherry-tagged version of the
mitochondrial Ca2+ uniporter, MCU, which results in a substan-
tial increase in the amplitude ofmitochondrial Ca2+ accumulation
(Drago et al., 2012), the mt-cAMP increases in response to both
NE and forskolin were strongly potentiated in Ca2+-containing
medium; on the contrary, in the absence of Ca2+ the cAMP
response was dramatically reduced. No significant difference
in nuclear cAMP increases was observed depending on the
presence/absence of Ca2+ in the medium (Figure S7).
DISCUSSION
For many years, the general consensus was that cAMP had no
role within mitochondria, despite the existence of numerous po-
tential PKA targets within this organelle (Technikova-Dobrova
et al., 1994; Zhao et al., 2011). Among the most relevant argu-
ments against a role of cAMP within mitochondria were: (1)
cAMP is negatively charged and, due to the negative potential
across the inner mitochondrial membrane, would tend to be
excluded from the matrix; (2) no recognizable signal sequence
is present either in the R or C PKA subunits; (3) all tmACs iso-
forms are localized at the plasma membrane. However, in the
last years the existence of a soluble AC has been unraveled,
and proteins recognized by antibodies against the PKA subunits
have been found in the mitochondrial matrix (Schwoch et al.,
1990). In addition, proteins such as AKAPs, Epac, PDEs, and
sAC appear to be associated with mitochondria (Acin-Perez
et al., 2009, 2011b; Breckler et al., 2011; Feliciello et al., 2001;
Sardanelli et al., 2006). Finally, increasing evidence supports a
key role of cAMP on the surface or in the matrix of the organelles
(Acin-Perez et al., 2011a; Alto et al., 2002; Danial et al., 2003;
Gomes et al., 2011; Harada et al., 1999; Sardanelli et al., 2006).
A key, yet unsolved, issue is whether cytosolic cAMP can enter
themitochondrial matrix. Unlike the results of DiPilato et al. (DiPi-
lato et al., 2004), our data clearly demonstrate that even massive
increases of cytosolic cAMP do not result in any significantCchange in mt-cAMP. Rather, our results indicate that mitochon-
dria are endowed with an intrinsic sAC that is activated by a
rise in matrix Ca2+ concentration and by HCO3
, while it is in-
hibited by blockers of sAC. We show that overexpression of a
matrix-targeted sAC and sAC-silencing result in potentiation or
inhibition, respectively, of the mt-cAMP increases elicited by
HCO3
, IBMX, and CCE; moreover, the effect of Ca2+ and
IBMX are potentiated by the presence of even low doses of
HCO3
. A matrix-located PDE, inhibited by a specific PDE2
blocker, is responsible for local cAMP hydrolysis, as PDE inhibi-
tion causes in itself a very small increase in mt-cAMP of resting
cells, and this effect is amplified when added on top of stimuli
activating sAC. Of note, the Ca2+ responsible for the cAMP in-
crease in the matrix is clearly that occurring within mitochondria
and not the cytoplasmic one, as overexpression of MCU in-
creases both mt-cAMP and Ca2+ levels, but reduces the cyto-
solic Ca2+ rises (De Stefani et al., 2011); in addition, silencing of
MCU significantly decreases mt-cAMP. Importantly, we show
that a matrix Ca2+ rise is a powerful stimulus to the generation
of mt-cAMP in a physiologically relevant system as primary
neonatal cardiomyocytes. Overall, these data clearly demon-
strate that cAMP changes do occur in the mitochondrial matrix
of living cells, independently from the cytosolic ones, and that
these mitochondrial changes are due to the concerted action of
intramitochondrial sAC and PDE. Most relevant, we show that a
rise in matrix Ca2+ represents a potent stimulus for cAMP gener-
ation, in particular if it occurs in the presence of HCO3
.
Of particular relevance appear the results in cardiomyocytes
stimulated with agents that, by activating tmACs, increase the
level of cytosolic cAMP, thus augmenting frequency and ampli-
tude of the spontaneous Ca2+ oscillations in the cytosolic and
mitochondrial compartment (Robert et al., 2001). In this physio-
logically relevant model, the mitochondrial cAMP increases do
not depend on the diffusion of the second messenger from the
cytosol to the matrix, but rather from an endogenous cAMP pro-
duction by the organelles, as in the cell lines model. This conclu-
sion is based on the following evidence: (1) the rise of mt-cAMP
is almost completely abolished by removal of extracellular Ca2+,
and (2) the mt-cAMP increase is augmented by increasing the
amplitude of the mitochondrial Ca2+ uptake, as induced by
MCU overexpression. Of note, the Ca2+ changes in the mito-
chondrial matrix are oscillatory, and each spike lasts 300–
500 ms, while the organelle cAMP increases take a few tens of
seconds to reach a new plateau level. Accordingly, this suggests
that the intramitochondrial cAMP homeostatic machinery is
capable of integrating an oscillatory Ca2+ signal in a prolonged
cAMP increase.
The key final questions concern the functional consequences
for mitochondrial metabolism of mt-cAMP changes and the
identification of the enzyme(s) that decode the cAMP level within
the organelle matrix. We show that the basal sAC activity modu-
lates [ATP]m, since increasing themitochondrial sAC level results
in a significant augmentation of mitochondrial ATP, while
reducing its activity or level, with drugs or siRNA, decreases
[ATP]m. Furthermore, the rise in mt-cAMP, obtained by blocking
PDEs or by activating CCE, increases [ATP]m. The interpretation
of the CCE effect on [ATP]m is, however, more complex, as the
rise of matrix Ca2+ also activates the NADH-linked dehydroge-
nases, and this in itself may be sufficient to increase respirationell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc. 973
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2011). Moreover, ATP itself has an inhibitory effect on sAC (Litvin
et al., 2003), and this substrate inhibition is relieved as the bicar-
bonate concentration increases. Therefore, Ca2+ could have a
further, indirect, effect on sAC, inasmuch as the dehydrogenase
activation increases respiration, and thus HCO3
 concentration,
and this could, through relieving the ATP inhibition, contribute to
a further sAC activation. We can speculate that the effects of
Ca2+ on the dehydrogenases and cAMP levels synergize to
insure an optimal flux of electrons in the respiratory chain and
an appropriate rate of ATP synthesis in stimulated cells.
As to the target of mt-cAMP, the most obvious candidate is
PKA. Indeed, evidence has been provided for the existence of
PKA within mitochondria (Sardanelli et al., 2006; Schwoch
et al., 1990; Acin-Perez et al., 2009), and we here show that
the effects of different agents on [ATP]m are inhibited not only
by the classical PKA inhibitor H89 (though its specificity is low)
or by Rp-8-CPT-cAMP, which competes with the cAMP binding
site of R-subunit, but also by a mitochondrial targeted PKI,
considered the most specific endogenous PKA inhibitor. We
can exclude that the effects on ATP are somehow mediated
through cytosolic cAMP, as neither 8Br-cAMP nor 8-CPT-6-
Phe-cAMP, potent activators of cytosolic PKA, increase
[ATP]m. On the contrary, 8-CPT-6-Phe-cAMP, which is consid-
ered the most specific activator of PKA, rather than stimulating
ATP production results in amodest reduction of ATP level. These
last unexpected pharmacological properties require further
investigation and suggest that the enzyme trapped in the mito-
chondrial matrix may possess unique properties compared to
canonical cytosolic PKA.
EXPERIMENTAL PROCEDURES
Fluorescence Resonance Energy Transfer Imaging
FRET imaging experiments were performed 24–48 hr after cell transfection or
in the stable line. Cells were maintained at room temperature (20C–22C) in
HEPES-buffered Ringer-modified saline (see Supplemental Information) sup-
plemented with CaCl2 (2 mM) or, alternatively, EGTA 100 mM (Ca
2+-free condi-
tions) and imaged with an inverted microscope (Olympus IX50) equipped with
a CellR imaging system and a beam-splitter optical device (Multispec Micro-
imager; Optical Insights). Images were acquired every 5 s (10 s during the
TMRM experiments) with a 603, 1.4 NA oil-immersion objective (Olympus) us-
ing the CellR software and processed using ImageJ (http://rsb.info.nih.gov/ij/).
FRET changes were measured as changes in the background-subtracted 480/
545 nm fluorescence emission intensities upon excitation at 430 nm and ex-
pressed as DR/R0, where R is the ratio at time t and R0 is the ratio at time =
0 s; DR = R  R0.
Confocal Imaging
Confocal images were acquired 24–48 hr after transfection or in the stable cell
line by using the broadband confocal Leica TCS SP5 system (Leica Microsys-
tems) and a HCX PL APO 633, 1.4 NA oil-immersion objective. Cells were
maintained in HEPES-buffered Ringer-modified saline (see Supplemental
Information) supplemented with 2 mM CaCl2, at room temperature
(20C–22C), and excited using the 458 nm line of an argon laser for imaging
CFP and the 543 nm line of a helium-neon laser for imaging mRFP.
ATP Measurements
To measure mitochondrial ATP levels, HeLa cells grown on 24-well plates at
60%–70% confluence were transfected with mitochondria-targeted luciferase
(mtLUC) or cotransfectedwithmtLUC and other cDNAs and/or treatedwith the
siRNAs. At 24–48 hr after transfection, luminescence experiments were car-
ried out. Thirty minutes before measurement, the medium was substituted974 Cell Metabolism 17, 965–975, June 4, 2013 ª2013 Elsevier Inc.with a HEPES-buffered Ringer-modified saline (identical to that used in
FRET CCE experiments), without CaCl2 and supplemented with 100 mM
EGTA and 100 mM luciferin, and cells were incubated at room temperature
(20C–22C). Luminescence was measured at room temperature with a
FLUOstar OPTIMA (BMG Labtechologies, Inc.), acquiring the luminescence
value from each well every minute, in plate mode. A baseline was established
in 15–20 cycles, each consisting of a full plate reading of the luminescence
values. Cells were then treatedwith the different reagents, as indicated. Values
recorded from wells containing untransfected cells were used as background,
and subtracted from the values of transfected cells.
Statistical Tests
In each graph, unless noted, data represent mean ± SEM of the indicated
number (n) of independent experiments. Statistical significance has been
calculated by a two-tailed Student’s t test (or, when indicated, by a two-tailed
Student’s paired t test). P values are indicated in the figure legends.SUPPLEMENTAL INFORMATION
Supplemental Information includes seven figures and Supplemental Experi-
mental Procedures and can be found with this article online at http://dx.doi.
org/10.1016/j.cmet.2013.05.003.
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